Q3 2024 Holdings
Filed 2024-11-14 | 278 holdings | $614.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $48.1M | 911,182 | 7.8% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $44.2M | 981,295 | 7.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $36.9M | 1,448,470 | 6.0% |
| EA Series Trust(BOXX) | ALPHA ARCH 1-3 | 02072L565 | $35.2M | 323,382 | 5.7% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $34.9M | 3,025,450 | 5.7% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $32.3M | 1,131,707 | 5.2% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $31.0M | 1,096,666 | 5.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $25.8M | 445,068 | 4.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $24.1M | 161,402 | 3.9% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $15.3M | 3,770,649 | 2.5% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $12.9M | 532,454 | 2.1% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $10.9M | 436,668 | 1.8% |
| AA Mission Acquisition Corp | ORD SHS CL A | G1000R101 | $10.1M | 1,010,199 | 1.6% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $8.8M | 729,401 | 1.4% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $8.0M | 2,089,321 | 1.3% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $8.0M | 1,145,592 | 1.3% |
| Merus N V | COM | N5749R100 | $7.7M | 153,286 | 1.2% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $7.6M | 1,571,705 | 1.2% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $7.5M | 750,000 | 1.2% |
| Xencor Inc(XNCR) | COM | 98401F105 | $6.9M | 342,262 | 1.1% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $6.7M | 350,206 | 1.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $6.5M | 192,720 | 1.1% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $6.0M | 521,612 | 1.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $6.0M | 569,008 | 1.0% |
| Biogen Inc(BIIB) | COM | 09062X103 | $5.7M | 29,625 | 0.9% |
| Omniab Inc(OABI) | COM | 68218J103 | $5.7M | 1,337,302 | 0.9% |
| CG Oncology Inc(CGON) | COM | 156944100 | $5.4M | 143,104 | 0.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $4.5M | 88,425 | 0.7% |
| Applied Therapeutics Inc(APLT)Call | COM | 03828A101 | $4.5M | 530,200 | 0.7% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $4.2M | 404,138 | 0.7% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $4.0M | 40,000 | 0.6% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $3.9M | 127,159 | 0.6% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $3.8M | 376,737 | 0.6% |
| Absci Corporation(ABSI) | COM | 00091E109 | $3.8M | 1,005,750 | 0.6% |
| Endeavor Group Hldgs Inc(0C3) | CL A COM | 29260Y109 | $3.5M | 122,807 | 0.6% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $3.4M | 57,183 | 0.5% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $3.3M | 118,738 | 0.5% |
| Savara Inc(SVRA) | COM | 805111101 | $3.1M | 742,634 | 0.5% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $3.0M | 101,826 | 0.5% |
| Acasti Pharma Inc(GRCE) | CL A | 00439U104 | $2.9M | 959,571 | 0.5% |
| Q32 BIO Inc(QTTB) | COM | 746964105 | $2.9M | 64,245 | 0.5% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $2.8M | 246,128 | 0.4% |
| Geron Corp(GERN) | COM | 374163103 | $2.5M | 557,159 | 0.4% |
| Pieris Pharmaceuticals Inc | COM NEW | 720795202 | $2.4M | 144,641 | 0.4% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $2.4M | 319,185 | 0.4% |
| Novo-Nordisk A S(NVO)Put | ADR | 670100205 | $2.4M | 20,000 | 0.4% |
| Cellectar Biosciences Inc(CLRBUSD) | COM NEW | 15117F807 | $2.2M | 1,022,161 | 0.4% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $2.1M | 74,431 | 0.3% |
| Syndax Pharmaceuticals Inc(SNDX)Call | COM | 87164F105 | $2.0M | 105,000 | 0.3% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $2.0M | 44,351 | 0.3% |